MarketScreener Strategies Kymera Therapeutics, Inc.
Stocks
KYMR
US5015751044
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.91 USD | +4.00% |
|
+7.88% | -1.16% |
| 06-09 | Kymera Therapeutics Unlocks $20 Million Milestone After Dosing First Participant in KT-485 Phase 1 Trial | MT |
| 06-08 | Kymera Therapeutics, Inc. Announces Executive Changes | CI |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- KYMR Stock
- News Kymera Therapeutics, Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition